Skip to content
value.today
Home Dialysis Plus, Ltd. logo

Home Dialysis Plus, Ltd.

Total raised
$397 M
6 rounds on record
Latest round
$115 M
Jan 2020
First round on record
Feb 2010
Today
Went public
See the company page

Home Dialysis Plus, Ltd. is listed today as Outset Medical, Inc.: market value, financials and filings are on its company page.

Funding rounds

6 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Home Dialysis Plus, Ltd.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2025$4 MPrivate placement after listing$2 to $10 million

Home Dialysis Plus, Ltd.: Private sale, Jan 2025

Investors in this round

13 investors had bought by the notice of Jan 21, 2025: 10 accredited, 3 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John T. Brottem · Executive Officer
  • Marc T. Nash · Executive Officer
  • Nabeel Ahmed · Executive Officer
  • Andrea Saia · Director
  • Brent Lang · Director
  • Dale Jones · Director
  • Karen T. Drexler · Director
  • Keith Grossman · Director
  • Leslie Trigg · Director
  • Patrick T. Hackett · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Nabeel Ahmed, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 21, 2025. Read the notice at the SEC.

equitySEC
Jan 2020$115 MNo. 6$50 to $250 million

Home Dialysis Plus, Ltd.: Raise no. 6, Jan 2020

Investors in this round

20 investors had bought by the notice of Feb 7, 2020: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$115 M of $129 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Leslie J. Trigg · Executive Officer, Director
  • Rebecca J. Chambers · Executive Officer
  • Camilla Macapili Languille · Director
  • D. Keith Grossman · Director
  • Patrick Hackett · Director
  • Rohit Vishnoi · Director
  • Scott Bartos · Director
  • Thomas J. Carella · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rebecca Chambers, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 7, 2020. Read the notice at the SEC.

equitySEC
Aug 2018$132 MNo. 5$50 to $250 million

Home Dialysis Plus, Ltd.: Raise no. 5, Aug 2018

Investors in this round

27 investors had bought by the notice of Aug 29, 2018: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$132 M of $143 M offered; $11 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Mack · Executive Officer
  • Leslie Trigg · Executive Officer, Director
  • Annette Rodriguez · Director
  • Camilla Macapili Languille · Director
  • D. Keith Grossman · Director
  • In Seon Hwang · Director
  • Rohit Vishnoi · Director
  • Scott Bartos · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeff Mack, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 29, 2018. Read the notice at the SEC.

equitySEC
Jun 2017$4 MNo. 4$2 to $10 million

Home Dialysis Plus, Ltd.: Raise no. 4, Jun 2017

Investors in this round

1 investor had bought by the notice of Jun 30, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Mack · Executive Officer
  • Leslie Trigg · Executive Officer, Director
  • Annette Rodriguez · Director
  • D. Keith Grossman · Director
  • In Seon Hwang · Director
  • Rohit Vishnoi · Director
  • Scott Bartos · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeff Mack, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 30, 2017. Read the notice at the SEC.

debt, optionsSEC
Apr 2017$76 MNo. 3$50 to $250 million

Home Dialysis Plus, Ltd.: Raise no. 3, Apr 2017

Investors in this round

27 investors had bought by the notice of May 3, 2017: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$76 M of $76 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Mack · Executive Officer
  • Leslie Trigg · Executive Officer, Director
  • Annette Rodriguez · Director
  • D. Keith Grossman · Director
  • In Seon Hwang · Director
  • Rohit Vishnoi · Director
  • Scott Bartos · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Leslie Trigg, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 3, 2017. Read the notice at the SEC.

equitySEC
May 2015$60 MNo. 2$50 to $250 million

Home Dialysis Plus, Ltd.: Raise no. 2, May 2015

Investors in this round

11 investors had bought by the notice of May 19, 2015: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$60 M of $66 M offered; $6 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Mack · Executive Officer
  • Leslie Trigg · Executive Officer, Director
  • Bess Weatherman · Director
  • D. Keith Grossman · Director
  • Noah Knauf · Director
  • Rohit Vishnoi · Director
  • Scott Bartos · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Leslie Trigg, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 19, 2015. Read the notice at the SEC.

equitySEC
Feb 2010$10 MNo. 1$2 to $10 million

Home Dialysis Plus, Ltd.: Raise no. 1, Feb 2010

Investors in this round

5 investors had bought by the notice of Feb 25, 2011: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Home Dialysis Plus, Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $50 M offered; $41 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joseph Rasmussen · Executive Officer · Joseph Rasmussen is the Chief Financial Officer and Secretary of the Issuer.
  • Elizabeth H. Weatherman · Director
  • Michael Baker · Director
  • Noah Knauf · Director
  • Sean Carney · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph Rasmussen, Chief Financial Officer and Secretary. Source: SEC Form D and 1 amendment, newest notice filed Feb 25, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Outset Medical, Inc., its revenue in fiscal 2025 came from these product and service lines: Consumables Product $54.08 million (45%), Service and Other Revenue $34.67 million (29%), Consoles Product $30.73 million (26%).

    Annual report (SEC XBRL) · Dec 2025

  • Home Dialysis Plus, Ltd. chose not to state its revenue in its newest notice of a funding round (Jan 2025).

    SEC Form D · Jan 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2025

Products and services#

No products or services of Home Dialysis Plus, Ltd. are on record.

Investors#

11 named in official filings. Open an investor to see everything it has backed.

Investors in Home Dialysis Plus, Ltd.
InvestorKindAmountRoundRoleSource
Warburg Pincus & CoOthernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus LLCFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus Partners GP LLCFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus Partners, L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus Private Equity X, L.P.Private equitynot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus X LLCOthernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus X, L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Warburg Pincus X Partners, L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
WPP GP LLCOthernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
WP X Finance, L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
WPX GP, L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 27 investors.

Largest shareholders today

Institutions holding Outset Medical, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Home Dialysis Plus, Ltd.
NameRoleNamed in
John T. BrottemExecutive officerJan 2025
Marc T. NashExecutive officerJan 2025
Nabeel AhmedExecutive officerJan 2025
Leslie J. TriggExecutive officerFeb 2020
Rebecca J. ChambersExecutive officerFeb 2020
Jeff MackExecutive officerAug 2018
Leslie TriggExecutive officerAug 2018
Joseph RasmussenJoseph Rasmussen is the Chief Financial Officer and Secretary of the Issuer.Feb 2011
Joseph J. RasmussenJoseph Rasmussen is the Chief Financial Officer and SecretaryFeb 2010
Michael J. BakerMichael J. Baker is the Chief Executive OfficerFeb 2010
Andrea SaiaDirectorJan 2025
Brent LangDirectorJan 2025
Dale JonesDirectorJan 2025
Karen T. DrexlerDirectorJan 2025
Keith GrossmanDirectorJan 2025
Leslie TriggDirectorJan 2025
Patrick T. HackettDirectorJan 2025
Camilla Macapili LanguilleDirectorFeb 2020
D. Keith GrossmanDirectorFeb 2020
Leslie J. TriggDirectorFeb 2020
Patrick HackettDirectorFeb 2020
Rohit VishnoiDirectorFeb 2020
Scott BartosDirectorFeb 2020
Thomas J. CarellaDirectorFeb 2020
Annette RodriguezDirectorAug 2018
In Seon HwangDirectorAug 2018
Tony ChouDirectorJun 2017
Bess WeathermanDirectorMay 2015
Noah KnaufDirectorMay 2015
Elizabeth H. WeathermanDirectorFeb 2011
Michael BakerDirectorFeb 2011
Sean CarneyDirectorFeb 2011

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.